CRG

General contacts
Investor type

PE / Debt fund

Founded

2003

AUM

$4 000 M

Location

Boulder, Colorado, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

Europe North America Asia
Investor profile last updated: 16 August, 2026

Profile

CRG is a global investment firm headquartered in Boulder, Colorado, and specializes in improving healthcare through strategic investments. With over 60 years of collective experience among its senior leadership, the firm is dedicated to providing tailored financial solutions that address capital needs within the healthcare sector. CRG is known for its expertise in healthcare private credit and select equity investments, managing over $4 billion in institutional capital. The firm differentiates itself with a singular focus on healthcare, aiming to create sustainable growth and long-term success for its partners.

CRG invests across various healthcare domains, including consumer health, life sciences, healthcare services, and healthcare IT. The firm offers flexible growth capital solutions, providing both credit and equity investments to a range of companies. Although the precise check size is not noted, the firm's substantial capital base suggests involvement in significant funding rounds. Geographically, CRG's investments span across healthcare sectors globally.

Notable investments by CRG include companies such as Aerin Medical, AFT Pharmaceuticals, Alignment Healthcare, Assertio, Astute Medical, and BioDelivery Sciences International. CRG's portfolio showcases a strong presence in diverse healthcare verticals, from medical devices to pharmaceutical services and healthcare IT solutions.

Industry

HealthTech Life Sciences Pharmaceuticals MedTech Healthcare Services Medical Devices Consumer Products Consumer Services (B2C) IT Services

CRG Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region 		Size AUM Launch date
Capital Royalty Partners II
Private Equity (PE)
Healthcare Services
Medical Devices
Life Sciences
Series B
Late Stage (Series C+)
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
$5-10 m
$805 M
May 2013
CRG Partners III
Private Equity (PE)
Healthcare Services
Medical Devices
Series B
Late Stage (Series C+)
North America
$5-10 m
$1500 M
January 2017
CRG Partners I LP
Private Equity (PE)
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
Series B
Late Stage (Series C+)
North America
$5-10 m
$325 M
June 2003
CRG Partners IV LP
Private Equity (PE)
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
Series B
Late Stage (Series C+)
North America
$5-10 m
$1400 M
November 2017
CRG Partners V
Private Equity (PE)
Debt fund
Medical Devices
IT Services
Healthcare Services
Consumer Services (B2C)
MedTech
Pharmaceuticals
Life Sciences
HealthTech
Series B
Late Stage (Series C+)
Europe
North America
Asia
$10-50 m
$546 M
January 2022

Contacts

Name
Title
Email
Social Networks
avatar
JP Giroux Vice President
Vice President
j•••@•••
LinkedIn
avatar
Luke Düster Chief Investment Officer
Chief Investment Officer
l•••@•••
LinkedIn
Upgrade to see contacts
avatar
VSDjAxCyh2mBdql1 VSDjAxCyh2mBdql1
VSDjAxCyh2mBdql1
[email protected]
linkedin twitter
avatar
VSDjAxCyh2mBdql1 VSDjAxCyh2mBdql1
VSDjAxCyh2mBdql1
[email protected]
linkedin twitter
avatar
VSDjAxCyh2mBdql1 VSDjAxCyh2mBdql1
VSDjAxCyh2mBdql1
[email protected]
linkedin twitter
Investment-team contacts for CRG — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about CRG

CRG is a private equity firm that also operates as a debt fund. It backs companies at Series B and Late Stage (Series C+), writing tickets of $10-50 m.
CRG is located in Boulder, Colorado, United States.
CRG was founded in 2003.
CRG invests in companies and startups in HealthTech, Life Sciences, Pharmaceuticals, MedTech, Healthcare Services, Medical Devices, Consumer Products, Consumer Services (B2C), IT Services.
CRG invests in companies and startups in Europe, North America, Asia.
CRG invests in companies and startups at Series B, Late Stage (Series C+).
CRG usually invests $10-50 m on average.
CRG has around $4 000m assets under management.
CRG last fund was created/launched in 2017-11-10
CRG can be reached through its website crglp.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for CRG — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query CRG directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.